Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Next Science | Main | Rewiring the Brain? »

March 8, 2005

The Latest from the Fume Hood

Email This Entry

Posted by Derek

Now, today's reaction in my hood looked like some chemistry, and no mistake. Bright yellow-green, and fizzing! Some of my readers may read that description and say "Hmmm. . .ethyl diazoacetate insertion reaction." Right you are. The color is from the diazo group - a lot of small diazo compounds have it, or so I hear. They tend to go ka-boom if handled roughly, so it's not like I have a big data set. Diazomethane (and its trimethylsilyl variation) are the only other ones I've seen, and I won't be broken up if the list doesn't get longer.

The fizzing is the diazo group breaking down, with nitrogen gas being given off as the compound reacts. Having a reaction that gives off a gaseous by-product is a wonderful way to drive the process to completion, since there's no way for the reaction to run in reverse once the gas has departed. And its formation is almost always a big downhill step for the free energy of the reaction, which puts thermodynamics on your side. Of course, that big leap to a lower energy state is something you don't want these things to just make on their own - that's where that ka-boom business comes in.

It's nice to have an indicator of success like those nitrogen bubbles; you know that you're probably not wasting your time. With diazomethane itself, you can watch its color disappear and know that something's happening. Another famous indicator is the smell of a Swern oxidation, which turns DMSO into stinky dimethyl sulfide. I agree with a friend from grad school who said that he'd come to actually enjoy the aroma, since it was the smell of success.

Most reactions, though, don't let you know what they're up to. They just look a little darker (well, often a lot darker) at the end than they did when they started. You have to interrogate them yourself, taking out a drop for thin-layer chromatography or some spectral technique. No problem with doing that, unless your reaction is being run at below-zero temperatures, in which case the sample you're removing has surely warmed up by the time you've analyzed it. It's a common beginner's mistake to check a cold reaction that way and conclude (prematurely) that it's finished. Live and learn.

Comments (3) + TrackBacks (0) | Category: Life in the Drug Labs


COMMENTS

1. The Novice Chemist on March 9, 2005 10:01 AM writes...


Aren't Swerns wonderful? I've come to really, really love them. Just like you said, I've come to check for the smell while I'm running a TLC to make sure that it's done. What metal are you using with the diazoacetate reaction? I've had little success with it...

Permalink to Comment

2. Derek Lowe on March 9, 2005 10:16 AM writes...

I'm using tin (II) chloride to react it with an aldehyde, as in JOC 54, 3258. Unfortunately, I can't go into details about what aldehyde I'm reacting it with and just why I'm doing that. But it looks like it worked, anyway.

Permalink to Comment

3. The Novice Chemist on March 9, 2005 1:21 PM writes...

Geez, Derek -- I've actually got that same paper. Looks like it worked better for your substrate than it did for mine... Just as well; I made the product with LDA and it did fine.

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings